Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS1 | Q07889 | 2/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12014706 | 0.98 | SOS1 (0.33) | SOS1GPR84PDK2 | |
| SCHEMBL12014701 | 0.96 | SOS1 (0.32) | SOS1PDK2 | |
| SCHEMBL15002731 | 0.96 | PDK2 (0.33) | SOS1PDK2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL12014681 | 0.96 | PDK2 (0.33) | SOS1PDK2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL15002775 | 0.95 | PDK2 (0.33) | SOS1PDK2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL15002733 | 0.95 | PDK2 (0.33) | SOS1PDK2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL15002699 | 0.94 | SOS1 (0.32) | SOS1GPR84 | |
| SCHEMBL12014698 | 0.94 | PDK2 (0.32) | SOS1PDK2 | |
| SCHEMBL15002744 | 0.94 | PDK2 (0.32) | SOS1PDK2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL12014683 | 0.94 | PDK2 (0.32) | SOS1PDK2CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013081410-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | 주식회사 두산 (KR) | 2013-06-06 | — | — | WO | disclosed |